BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10650538)

  • 1. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers.
    Masson CL; Gilbert DG
    J Behav Med; 1999 Dec; 22(6):589-604. PubMed ID: 10650538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress.
    Davis MC; Matthews KA
    Health Psychol; 1990; 9(6):717-36. PubMed ID: 2286182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women.
    Davis MC
    Health Psychol; 1999 Mar; 18(2):122-30. PubMed ID: 10194047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking and cycle control among oral contraceptive users.
    Rosenberg MJ; Waugh MS; Stevens CM
    Am J Obstet Gynecol; 1996 Feb; 174(2):628-32. PubMed ID: 8623797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.
    Roy S
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S364-8. PubMed ID: 10368522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
    Straznicky NE; Barrington VE; Branley P; Louis WJ
    J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use.
    Levine SR; Fagan SC; Pessin MS; Silbergleit R; Floberg J; Selwa JF; Vogel CM; Welch KM
    Neurology; 1991 Dec; 41(12):1893-901. PubMed ID: 1745344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood changes during the menstrual cycle and their relation to the use of oral contraceptive.
    Almagor M; Ben-Porath YS
    J Psychosom Res; 1991; 35(6):721-8. PubMed ID: 1791586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.
    Croft JB; Freedman DS; Cresanta JL; Srinivasan SR; Burke GL; Hunter SM; Webber LS; Smoak CG; Berenson GS
    Am J Epidemiol; 1987 Aug; 126(2):202-13. PubMed ID: 3605049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of cigarette smoking, oral contraceptive use, and cardiovascular risk factor variables in children: the Bogalusa Heart Study.
    Webber LS; Hunter SM; Baugh JG; Srinivasan SR; Sklov MC; Berenson GS
    Am J Public Health; 1982 Mar; 72(3):266-74. PubMed ID: 7058967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that smoking alters prostacyclin formation and platelet aggregation in women who use oral contraceptives.
    Mileikowsky GN; Nadler JL; Huey F; Francis R; Roy S
    Am J Obstet Gynecol; 1988 Dec; 159(6):1547-52. PubMed ID: 3061301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between mood and sexuality in women using an oral contraceptive as a treatment for premenstrual symptoms.
    Graham CA; Sherwin BB
    Psychoneuroendocrinology; 1993; 18(4):273-81. PubMed ID: 8316616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke.
    Castelli WP
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S349-56. PubMed ID: 10368520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The menstrual cycle from a bio-behavioral approach: a comparison of oral contraceptive and non-contraceptive users.
    Garrett KF; Elder ST
    Int J Psychophysiol; 1984 Feb; 1(2):209-14. PubMed ID: 6542080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interactions of body weight, age, cigarette smoking and hormone usage with blood pressure and plasma lipids in an Australian community.
    Simons LA; Simons J; Jones AS
    Aust N Z J Med; 1984 Jun; 14(3):215-21. PubMed ID: 6594111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oral contraceptive user.
    Lidegaard O; Overgaard K; Hauch O
    Acta Obstet Gynecol Scand; 1988; 67(1):27-31. PubMed ID: 3176910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.